Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Fusion Genes, Version 3.2021

This is a clinical practice guideline for patients with myeloid or lymphoid neoplasms with eosinophilia (MLN-Eo) and tyrosine kinase fusion genes. The guideline provides recommendations for the diagnosis, staging, and treatment of these patients. Specific topics discussed include cytogenic and molecular testing, the role of next-generation sequencing, the evaluation of organ involvement, as well as various chemotherapy regimens.